📰 Neil Kumar News
Page 2 - Neil Kumar News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Neil Kumar. Real-time updates on events, politics, business and more.
March 1, 2024
Raj Singh was standing outside the gurdwara when a group of unidentified assailants approached him and fatally shot him in the abdomen. - Sikh Man From Bijnor Shot Dead Outside Gurudwara In US Alabama, Was A Ragi With Kirtan Group
February 28, 2024
US & Canada News News: A musician (ragi) with a Sikh kirtan group was shot dead outside a gurdwara at Selma in the US state of Alabama in a case of suspected hate crime on Saturday.
February 22, 2024
- Submitted New Drug Application to US Food and Drug Administration for acoramidis for the treatment of transthyretin amyloid cardiomyopathy based on positive results of Phase 3 ATTRibute-CM trial,...
February 9, 2024
The upfront payment pads BridgeBio’s balance sheet as the company gears up for the anticipated launch of another drug, ATTR-CM med acoramidas.
February 7, 2024
- BridgeBio grants Kyowa Kirin exclusive license to develop and commercialize infigratinib for skeletal dysplasias in Japan - BridgeBio to receive upfront payment of USD 100 million with...
February 7, 2024
- BridgeBio grants Kyowa Kirin exclusive license to develop and commercialize infigratinib for skeletal dysplasias in Japan - BridgeBio to receive...
November 16, 2023
REITs and private real estate investment funds offer exposure to market, but dont scrimp on due diligence. Read more from
October 23, 2023
A scientific journal article sheds new light on the insane 18K x 18K image sensor being used to make content for Sphere in Las Vegas.
October 17, 2023
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average twelve-month price target […]
October 14, 2023
Moody Aldrich Partners LLC lessened its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 44.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,873 shares of the company’s stock after selling 64,980 shares during the period. Moody […]